LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-13.16%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.18B
AUM Growth
+$1.18B
(-7.3%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
8.72%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18
Top Buys
| 1 |
DexCom
DXCM
|
$17.3M |
| 2 |
Manulife Financial
MFC
|
$6.87M |
| 3 |
Glaukos
GKOS
|
$6.71M |
| 4 |
Republic Services
RSG
|
$6.09M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$5.8M |
Top Sells
| 1 |
AbbVie
ABBV
|
$11.7M |
| 2 |
UnitedHealth
UNH
|
$11.6M |
| 3 |
Halozyme
HALO
|
$8.48M |
| 4 |
iRhythm Technologies
IRTC
|
$7.85M |
| 5 |
CRISPR Therapeutics
CRSP
|
$7.72M |
Sector Composition
| 1 | Healthcare | 46.65% |
| 2 | Financials | 13.97% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Technology | 8.36% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
76
DELISTED
Ansys
ANSS
| $3.77M | 0.32% |
+15,752
| New | +$3.77M |
|
77
Coca-Cola
KO
$297B
| $3.68M | 0.31% |
58,446
+5,383
| +10% | +$339K |
|
78
Itaú Unibanco
ITUB
$77B
| $3.64M | 0.31% |
850,000
-402,600
| -32% | -$1.72M |
|
79
Procter & Gamble
PG
$368B
| $3.59M | 0.3% |
24,996
+1,517
| +6% | +$218K |
|
80
Allogene Therapeutics
ALLO
$251M
| $3.48M | 0.29% |
305,253
-195,966
| -39% | -$2.23M |
|
81
PepsiCo
PEP
$204B
| $3.47M | 0.29% |
20,832
-1,741
| -8% | -$290K |
|
82
Alexandria Real Estate Equities
ARE
$14.1B
| $3.46M | 0.29% |
+23,874
| New | +$3.46M |
|
83
10x Genomics
TXG
$1.74B
| $3.42M | 0.29% |
75,594
-4,682
| -6% | -$212K |
|
84
Intellia Therapeutics
NTLA
$1.22B
| $3.38M | 0.29% |
65,316
-13,773
| -17% | -$713K |
|
|
SIVB
85
DELISTED
SVB Financial Group
SIVB
| $3.35M | 0.28% |
+8,474
| New | +$3.35M |
|
86
NextEra Energy, Inc.
NEE
$148B
| $3.29M | 0.28% |
42,518
+7,555
| +22% | +$585K |
|
87
Danaher
DHR
$147B
| $3.28M | 0.28% |
12,925
+609
| +5% | +$154K |
|
88
Corpay
CPAY
$23B
| $3.27M | 0.28% |
+15,557
| New | +$3.27M |
|
89
Natera
NTRA
$23.1B
| $3.26M | 0.28% |
91,949
-106,875
| -54% | -$3.79M |
|
90
Sangamo Therapeutics
SGMO
$157M
| $3.22M | 0.27% |
778,769
-81,933
| -10% | -$339K |
|
91
Fate Therapeutics
FATE
$120M
| $3.2M | 0.27% |
129,213
-42,112
| -25% | -$1.04M |
|
92
Applied Materials
AMAT
$128B
| $3.14M | 0.27% |
34,513
+22,460
| +186% | +$2.04M |
|
93
Editas Medicine
EDIT
$231M
| $3.07M | 0.26% |
259,832
-121,131
| -32% | -$1.43M |
|
94
Elanco Animal Health
ELAN
$9.12B
| $2.95M | 0.25% |
+150,448
| New | +$2.95M |
|
95
Nike
NKE
$114B
| $2.9M | 0.25% |
28,411
+198
| +0.7% | +$20.2K |
|
96
Yeti Holdings
YETI
$2.86B
| $2.84M | 0.24% |
+65,729
| New | +$2.84M |
|
97
Y-mAbs Therapeutics
YMAB
$388M
| $2.74M | 0.23% |
180,933
-40,841
| -18% | -$618K |
|
|
AZPN
98
DELISTED
Aspen Technology Inc
AZPN
| $2.67M | 0.23% |
+14,512
| New | +$2.67M |
|
99
Estee Lauder
EL
$33B
| $2.62M | 0.22% |
+10,292
| New | +$2.62M |
|
100
CareDx
CDNA
$727M
| $2.62M | 0.22% |
121,879
+63,327
| +108% | +$1.36M |
|